The House is set to vote this week on its drug-pricing bill, but the outlook for an ultimate deal continues to look not great.
Driving the news: House leaders may bring the bill to the floor without an amendment from Rep. Pramila Jayapal, a progressive stalwart.
- That has prompted progressive Democrats to consider trying to block a vote on the bill, The Hill's Peter Alexander reported Friday.
Where it stands: The White House has already criticized Pelosi's bill, and pushback from the left obviously wouldn't help its chances.
- The Senate's bill is really the one to watch, but it has much less support from leadership.
- In short, a lot of frayed alliances — between Pelosi and the left, Pelosi and Trump, pharma critics and McConnell — would need to un-fray in order for anything to happen here. And the clock is running out.
Go deeper:
